量研学術機関リポジトリ「QST-Repository」は、国立研究開発法人 量子科学技術研究開発機構に所属する職員等が生み出した学術成果(学会誌発表論文、学会発表、研究開発報告書、特許等)を集積しインターネット上で広く公開するサービスです。 Welcome to QST-Repository where we accumulates and discloses the academic research results(Journal Publications, Conference presentation, Research and Development Report, Patent, etc.) of the members of National Institutes for Quantum Science and Technology.
Thank you very much for using our website. On the 11th of March 2019, this site was moved from our own network server to the JAIRO Cloud network server. If you previously bookmarked this site, that bookmark will no longer work. We would be grateful if you could bookmark the website again. Thank you very much for your understanding and cooperation.
ntroduction: Cancer stem cells are recently noticed to contribute to tumor malignant behaviors, such as resistance to therapy and metastasis ability in tumors. On the other hand, it has been also known that tumor hypoxia is associated with such tumor malignancy. This indicates that tumor hypoxia might be a specific environment to keep up cancer stem cells within tumors. In this study, we examined relationships between existence of cancer stem cells and accumulation of hypoxia imaging agent 64Cu-diacetyl-bis (N4-methylthiosemicarbazone) (64Cu-ATSM) in vivo and conducted in vitro characterization. Methods: Double-tracer autoradiography and immunohistchemistry was performed with mouse colon carcinoma (Colon-26) tumor-bearing mice. In autoradiography, mixture of 74 MBq of 18FDG and 0.37 MBq of 64Cu-ATSM was intravenously injected. The distribution of radio-labeled tracers was compared with the immunohistochemical staining for CD133 expression, which reflected the characteristic of cancer stem cells in Colon-26 cells. Additionally, 64Cu-ATSM uptake and survival of CD133+ cells under hypoxia was also examined with Colon-26 cells in vitro. Results: In Colon-26 tumors, 64Cu-ATSM localizes preferentially in regions with a high density of CD133+ cells. Density of CD133+ cells was highest in regions of high 64Cu-ATSM uptake and lowest in regions of high uptake of 18FDG. In addition, we found that in vitro culturing of Colon-26 cells under hypoxia increased both 64Cu-ATSM uptake and the proportion of CD133+ cells present. Conclusion: Our findings show that, in Colon-26 tumors, 64Cu-ATSM accumulates in CD133+ cell-rich regions and that these cells would be resistant to hypoxic environment. Therefore, 64Cu-ATSM could be a potential imaging agent for cancer stem cell-rich regions within tumors.